![Blood & Cancer artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/1e/c2/c2/1ec2c24b-87c4-8ff6-ba9e-d81a8cbb12eb/mza_1867652355606483784.png/100x100bb.jpg)
Hem-Onc News: Delaying radiotherapy for high-risk prostate cancer; melanoma experts say 'no' to routine gene profile testing
Blood & Cancer
English - September 08, 2020 21:48 - 11 minutes - 22.3 MB - ★★★★★ - 31 ratingsMedicine Health & Fitness Science Life Sciences oncologists radiotherapy cancer chemotherapy doctors healthcare hematologists hematology immunotherapy marrow Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Best of the 2020 American Society of Clinical Oncology Annual Meeting
Blood & Cancer News: Delaying RT for higher-risk prostate cancer found safe: https://bit.ly/2F1cKoQ
Source: https://bit.ly/2FaaMCr
RTOG 9413: https://bit.ly/2DL2FM4
RTOG 9910: https://bit.ly/2F8itJe HOME-PE trial clarifies which pulmonary embolism patients to treat at home: https://bit.ly/3ibNTN9
Melanoma experts say ‘no’ to routine gene profile testing: https://bit.ly/2Zka10p
Source: https://bit.ly/2ZkzerB
VTE, sepsis risk increased among COVID-19 patients with cancer: https://bit.ly/2DL2Wi4
You can learn more about Blood & Cancer at https://www.mdedge.com/podcasts/blood-cancer